Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For NDSN
Valuation Weak
14%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Weak
17%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q2 Δ in %
Current Ratio 4.73 2.21 2.11
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 1.86 7.58 7.45
Naive Interpretation member
2 Per Share
Metric Q4 Q2 Δ in %
Book Value 6.94 48.73 45.56
Cash 8.06 2.19 2.03
Capex -38.57 -0.25 -0.18
Free Cash Flow -29.45 1.89 2.68
Revenue -9.87 11.37 12.62
Naive Interpretation member
3 Profitability
Metric Q4 Q2 Δ in %
Gross Margin 5.31 0.56 0.53
Operating Margin 0.74 0.26 0.26
ROA -6.05 0.02 0.02
ROE -13.79 0.04 0.05
ROIC -9.49 0.03 0.03
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of NDSN is permitted for members.
5 Growth
The "Growth Entry" for the Focus of NDSN is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of NDSN is permitted for members.